
A medication used to manage type 2 diabetes has been found effective in treating sleep apnea. The worldwide clinical trial demonstrates that tirzepatide significantly lowers breathing interruptions during sleep, a key indicator of the severity of a patient’s obstructive sleep apnea (OSA). Tirzepatide is one of the class of blockbuster GLP-1 medicines, sold as Mounjaro… read on > read on >